综述

Lipin家族研究进展

展开
  • 1. 韶关学院英东生物工程学院, 韶关 512005; 
    2. 华南农业大学动科院, 广州510642; 
    3. 广东工业大学轻工化工学院, 广州510006; 
    4. 浙江大学饲料研究所, 杭州310029

收稿日期: 2010-01-06

  修回日期: 2010-04-08

  网络出版日期: 2010-10-20

基金资助

韶关市科技局重点科研项目(编号:313-140348)和韶关学院重点科研课题资助项目(编号:2008-182)资助

Research and development of Lipin family

Expand
  • 1. College of Yingdong Bioengineering, Shaoguan University, Shaoguan 512005, China
    2. College of Animal Science, South China Agricultural University, Guangzhou 510642, China;
    3. Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China;
    4. Institute of Feed Science, Zhejiang University, Hangzhou 310029, China

Received date: 2010-01-06

  Revised date: 2010-04-08

  Online published: 2010-10-20

摘要

Lipin家族主要包括Lipin 1、Lipin 2与Lipin 3等成员, 是第一个能够双向调控机体脂类代谢的关键调节酶, 不但在脂肪代谢中起调节作用, 还在保持正常的外周神经功能、肝脏脂蛋白分泌、细胞形态、生殖性能及能量稳态等方面发挥着重要的生理功能。Lipin家族基因表达的轻微变异可能与艾滋病、胰岛素抵抗、肥胖症、糖尿病以及代谢综合征中的其他疾病相关, 并有可能成为上述临床疾病治疗的新靶点。文章就Lipin的发现、结构特点、表达与调控、生理功能及其与临床疾病的联系等研究成果进行概述。

本文引用格式

唐胜球,江青艳,杨楚芬,邹晓庭,董小英 . Lipin家族研究进展[J]. 遗传, 2010 , 32(10) : 981 -993 . DOI: 10.3724/SP.J.1005.2010.00981

Abstract

Lipin family including at least three members Lipin 1, Lipin 2, and Lipin 3 is a critical regulatory enzyme identified recently, which plays dual roles in lipid metabolisms. Lipin family has physiological effects not only on regulating lipid metabalism, but also on maintaining normal peripheral nervous functions, liver lipoprotein secretion, cell morphous, reproductive functions, and energy homeostasis. Since mutations in Lipin gene express may be associated with AIDS, insulin resistance, obesity, diabetes mellitus, and the other diseases of metabolic syndrome, Lipin may be a new useful target in treatment of above-mentioned clinical-related diseases. In this article, we focused on discovery, construction features, expression, regulatory mechanism, and biological functions of Lipin, as well as its correlation research with clinical-related diseases.

参考文献

[1] Garg A. Acquired and inherited lipodystrophies. N Engl J Med, 2004, 350(1): 1220–1234. [2] Hegele RA, Joy TR, Al-Attar S, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res, 2007, 48(7): 1433–1444. [3] Reue K, Phan J. Metabolic consequences of lipodystrophy in mouse models. Curr Opin Clin Nutr Metab Care, 2006, 9(4): 436–441. [4] Ahima RS. Adipose tissue as an endocrine organ. Obesity, 2006, 14(Suppl. 5): 242S–249S. [5] Unger RH. Lipotoxic diseases. Annu Rev Med, 2002, 53(1): 319–336. [6] Farmer SR. Transcriptional control of adipocyte formation. Cell Metab, 2006, 4(4): 263–273. [7] Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Na Rev Mol Cell Biol, 2006, 7(12): 885–896. [8] Phan J, Péterfy M, Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J Biol Chem, 2004, 279(28): 29558–29564. [9] van Harmelen V, Ryden M, Sjolin E, Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res, 2007, 48(1): 201–206. [10] Langner CA, Birkenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. The fatty liver dys-trophy (fld) mutation. A new mutant mouse with a devel-opmental abnormality in triglyceride metabolism and as-sociated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem, 1989, 264(14): 7994–8003. [11] Langner CA, Birkenmeier EH, Roth KA, Bronson RT, Gordon JI. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J Biol Chem, 1991, 266(18): 11955–11964. [12] Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue defi-ciency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res, 2000, 41(7): 1067–1076. [13] Péterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet, 2001, 27(1): 121–124. [14] Huffman TA, Mothe-Satney I, Lawrence JC Jr. Insu-lin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci USA, 2002, 99(2): 1047–1052. [15] Péterfy M, Phan J, Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem, 2005, 280(38): 32883–32889. [16] Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an induc-ible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab, 2006, 4(3): 199–210. [17] Han GS, Wu WI, Carman GM. The Saccharomyces cere-visiae lipin homolog is an Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem, 2006, 281(14): 9210–9218. [18] Han GS, Siniossoglou S, Carman GM. The cellular func-tions of the yeast lipin homolog PAH1p are dependent on its phosphatidate phosphatase activity. J Biol Chem, 2007, 282(51): 37026–37035. [19] O'Hara L, Han GS, Peak-Chew S, Grimsey N, Carman GM, Siniossoglou S. Control of phospholipid synthesis by phosphorylation of the yeast lipin Pah1p/Smp2p Mg2+-dependent phosphatidate phosphatase. J Biol Chem, 2006, 281(45): 34537–34548. [20] He XP, Xu XW, Zhao SH, Fan B, Yu M, Zhu MJ, Li CC, Peng ZZ, Liu B. Investigation of Lpin1 as a candidate gene for fat deposition in pigs. Mol Biol Rep, 2009, 36(5): 1175–1180. [21] He XP, Xu XW, Liu B. Molecular characterization, chro-mosomal locali
文章导航

/